Sanofi SA (SAN) Given a €71.00 Price Target at JPMorgan Chase & Co.
Sanofi SA (EPA:SAN) received a €71.00 ($78.89) target price from analysts at JPMorgan Chase & Co. in a research note issued on Thursday. The brokerage currently has a a “sell” rating on the stock.
A number of other equities analysts have also recently issued reports on SAN. Baader Bank set a €78.00 ($86.67) price objective on shares of Sanofi SA and gave the company a “neutral” rating in a research note on Thursday, June 9th. Jefferies Group set a €76.00 ($84.44) target price on shares of Sanofi SA and gave the stock a “neutral” rating in a report on Tuesday, June 14th. Independent Research GmbH set a €77.00 ($85.56) target price on shares of Sanofi SA and gave the stock a “neutral” rating in a report on Thursday, June 30th. Kepler Capital Markets set a €91.00 ($101.11) target price on shares of Sanofi SA and gave the stock a “buy” rating in a report on Thursday, July 7th. Finally, Societe Generale set a €100.00 ($111.11) target price on shares of Sanofi SA and gave the stock a “buy” rating in a report on Monday, August 1st. One analyst has rated the stock with a sell rating, nine have given a hold rating and seven have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of €86.76 ($96.41).
Shares of Sanofi SA (EPA:SAN) opened at 68.92 on Thursday. The firm has a 50-day moving average price of €25.99 and a 200-day moving average price of €25.70. Sanofi SA has a 52-week low of €22.81 and a 52-week high of €69.59. The firm has a market capitalization of €88.70 billion and a P/E ratio of 21.43.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/15/sanofi-sa-san-given-a-71-00-price-target-at-jpmorgan-chase-co.html
About Sanofi SA
Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products.
Receive News & Ratings for Sanofi SA Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sanofi SA and related companies with MarketBeat.com’s FREE daily email newsletter.